Frontier Wealth Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-151,750
| Closed | -$1.49M | – | 368 |
|
|
2020
Q1 | $1.49M | Sell |
151,750
-45,000
| -23% | -$443K | 0.24% | 95 |
|
|
2019
Q4 | $2.18M | Sell |
196,750
-30,000
| -13% | -$333K | 0.35% | 67 |
|
|
2019
Q3 | $1.27M | Buy |
226,750
+20,000
| +10% | +$112K | 0.19% | 111 |
|
|
2019
Q2 | $1.79M | Buy |
206,750
+45,000
| +28% | +$389K | 0.26% | 81 |
|
|
2019
Q1 | $1.3M | Buy |
161,750
+131,750
| +439% | +$1.06M | 0.18% | 127 |
|
|
2018
Q4 | $123K | Hold |
30,000
| – | – | 0.02% | 338 |
|
|
2018
Q3 | $168K | Buy |
30,000
+5,000
| +20% | +$28K | 0.02% | 368 |
|
|
2018
Q2 | $329K | Sell |
25,000
-5,000
| -17% | -$65.8K | 0.05% | 280 |
|
|
2018
Q1 | $426K | Buy |
+30,000
| New | +$426K | 0.06% | 246 |
|
|
2017
Q4 | – | Sell |
-50,000
| Closed | -$593K | – | 395 |
|
|
2017
Q3 | $593K | Hold |
50,000
| – | – | 0.09% | 201 |
|
|
2017
Q2 | $503K | Hold |
50,000
| – | – | 0.08% | 225 |
|
|
2017
Q1 | $583K | Hold |
50,000
| – | – | 0.09% | 203 |
|
|
2016
Q4 | $233K | Buy |
50,000
+15,000
| +43% | +$69.9K | 0.04% | 331 |
|
|
2016
Q3 | $271K | Buy |
+35,000
| New | +$271K | 0.04% | 294 |
|